查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1619216

血液检测市场规模、份额、成长分析，按类型、方法、最终用户、地区划分 - 产业预测，2024-2031 年

Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球血液检测市场规模估值为956.5亿美元，从2023年的1034.9亿美元增长到2031年的1944.2亿美元，预计在预测期内（2024-2031年）将增长。为8.2%）。

由于政府和私营部门医疗保健支出的增加，预计全球血液检测市场将显着增长。跨国医疗机构积极开发创新技术并提高人们对慢性病的认识，进一步推动血液检测的需求。慢性病（尤其是糖尿病）的增加预计到 2031 年将影响 7.83 亿成年人，这对健康评估产品产生了巨大的需求。 CMS 和 FDA 等监管机构对于推广符合 CLIA 的诊断测试至关重要，以加强疾病的早期发现。监管支持的激增和对健康问题的日益关注，为血液检测领域的企业提供了利润丰厚的机会，并为未来几年的市场强劲扩张奠定了基础。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数（2023）
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 技术进步
  • 监管环境
  • 案例研究
  • 专利分析

血液检测市场规模：按类型和复合年增长率（2024-2031）

  • 市场概况
  • 血糖测试
  • 血脂检查
  • 前列腺特异性抗原（PSA）测试
  • 血中尿素氮（BUN）测试
  • 甲状腺刺激素测试
  • 其他类型
    • 直接低密度脂蛋白测试
    • 睪酮测试

血液检测市场规模：依方法及复合年增长率（2024-2031）

  • 市场概况
  • 手动验血
  • 自动验血

血液检测市场规模：依最终用户和复合年增长率（2024-2031）

  • 市场概况
  • 诊断实验室
  • 医院
  • 其他最终用户

血液检测市场规模：按地区及复合年增长率（2024-2031）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析（2023）
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较（2021-2023）

主要企业简介

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • bioMerieux
  • Quest Diagnostics Incorporated
  • Biomerica
  • BD
  • Siemens Healthineers AG
  • Danaher Corporation
  • Trinity Biotech Plc
  • Thermo Fisher Scientific
  • Sysmex Corporation
  • Dr Lal PathLabs Limited
  • Alere Inc.
  • Cepheid Corporation

结论和建议

简介目录
Product Code: SQMIG35A2519

Global Blood Testing Market size was valued at USD 95.65 billion in 2022 and is poised to grow from USD 103.49 billion in 2023 to USD 194.42 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031).

The global blood testing market is projected to experience significant growth, fueled by increasing medical expenditures from both government and private sectors. Multinational healthcare organizations are actively developing innovative techniques and raising awareness about chronic diseases, further driving demand for blood testing. The rise in chronic disease prevalence, especially diabetes-expected to affect 783 million adults by 2031-will create substantial demand for health assessment products. Regulatory bodies like CMS and FDA are pivotal in promoting CLIA-compliant diagnostic tests that enhance early disease detection. This surge in regulatory support and rising health concerns offers lucrative opportunities for operational entities within the blood testing sector, positioning it for robust market expansion in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Testing Market Segmental Analysis

Global Blood Testing Market is segmented by type, methods, end user and region. Based on type, the market is segmented into glucose testing, lipid panel testing, prostate specific antigen (PSA) testing, blood urea nitrogen (BUN) testing, thyroid stimulating hormone testing and other types (Direct LDL Testing, Testosterone Testing). Based on methods, the market is segmented into manual blood testing and automated blood testing. Based on end user, the market is segmented into diagnostic laboratories, hospitals and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Testing Market

The Global Blood Testing market is significantly influenced by several key drivers that contribute to its growth. One of the most crucial factors is the influx of external funding directed towards clinical studies focused on innovating advanced diagnostic technologies. Additionally, as patient awareness regarding various self-testing and home diagnostic options rises, this trend is expected to further boost the market. Moreover, the increasing prevalence of chronic diseases, coupled with a heightened demand for rapid health assessment products, suggests a strong upward trajectory for the global blood testing market in the upcoming years. These elements collectively create a favorable environment for market expansion.

Restraints in the Global Blood Testing Market

The Global Blood Testing market faces significant challenges that may impede its growth, particularly in developing nations like India, Indonesia, and Malaysia. A key restraint is the limited awareness among patients regarding advanced technological devices, which can inhibit adoption rates. Additionally, the high costs associated with these devices and self-testing kits are anticipated to further suppress market demand in the foreseeable future. These factors collectively contribute to a slower market advancement, highlighting the need for increased education and more affordable options to enhance accessibility and utilization of blood testing technologies in these regions.

Market Trends of the Global Blood Testing Market

The global blood testing market is witnessing significant growth driven by advancements in technology and a surge in demand for accurate diagnostic solutions. Key players are increasingly leveraging innovations, particularly Artificial Intelligence, to enhance the precision and speed of disease detection, enabling early intervention and improved patient outcomes. This focus on integrating cutting-edge technologies not only streamlines testing processes but also caters to the evolving needs of healthcare providers and patients alike. As a result, the market is poised for expansion, with a notable emphasis on developing user-friendly products that enhance accessibility and efficiency, thereby reshaping the landscape of blood diagnostics worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Patent Analysis

Global Blood Testing Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • Glucose Testing
  • Lipid Panel Testing
  • Prostate Specific Antigen (PSA) Testing
  • Blood Urea Nitrogen (BUN) Testing
  • Thyroid Stimulating Hormone Testing
  • Other Types
    • Direct LDL Testing
    • Testosterone Testing

Global Blood Testing Market Size by Methods & CAGR (2024-2031)

  • Market Overview
  • Manual Blood Testing
  • Automated Blood Testing

Global Blood Testing Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

Global Blood Testing Market Size & CAGR (2024-2031)

  • North America (Type, Methods, End User)
    • USA
    • Canada
  • Europe (Type, Methods, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Methods, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Methods, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Methods, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biomerica
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trinity Biotech Plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Lal PathLabs Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alere Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations